Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin add-on therapy in schizophrenia with elevated CRP
2014-000757-36Phase 3Completed
- Sponsor
- CliniRx
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia and schizoaffective disorder comparing Aspirin add-on with Placebo add-on (2 arms). Primary endpoint: PANSS total score. Started May 2014; status: completed.
02
Drugs
aspirin
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2014-000757-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000757-36.